Intuitive SurgicalMEX:ISRG 91 Return-on-Tangible-Equity is 19.27% as of Mar. 2026, which is 23% above its 10-year median of 15.70. GuruFocus rates MEX:ISRG with a GF Score™ of 91/100 and a GF Value™ of MXN10,532.16 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 759 Medical Devices & Instruments companies, Intuitive Surgical ranks better than 80.76% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Intuitive Surgical's annualized net income for the quarter that ended in Mar. 2026 was MXN59,255 Mil. Intuitive Surgical's average shareholder tangible equity for the quarter that ended in Mar. 2026 was MXN307,550 Mil. Therefore, Intuitive Surgical's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 19.27%.
The historical rank and industry rank for Intuitive Surgical's Return-on-Tangible-Equity or its related term are showing as below:
MEX:ISRG'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 11.95 Med: 15.7 Max: 20.65
Current: 17.54
During the past 13 years, Intuitive Surgical's highest Return-on-Tangible-Equity was 20.65%. The lowest was 11.95%. And the median was 15.70%.
MEX:ISRG's Return-on-Tangible-Equity is ranked better than 80.76% of 759
companies
in the Medical Devices & Instruments industry
Industry Median: 4.07
vs MEX:ISRG: 17.54
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Intuitive Surgical Return-on-Tangible-Equity Related Terms
Intuitive Surgical Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Intuitive Surgical's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:ISRG vs BDX, MDLN, RMD: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Intuitive Surgical's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intuitive Surgical Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intuitive Surgical's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Intuitive Surgical's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 19.27% mean?
Intuitive Surgical (MEX:ISRG) has a Return-on-Tangible-Equity of 19.27% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Intuitive Surgical and its competitors. This is 23% above median its historical median of 15.70. Over the past decade, Intuitive Surgical's Return-on-Tangible-Equity has ranged from 11.95 to 20.65. According to the industry distribution chart, Intuitive Surgical ranks #146 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 19.2%.
Is Intuitive Surgical's Return-on-Tangible-Equity too high?
Intuitive Surgical's current Return-on-Tangible-Equity of 19.27% is 23% above median its 10-year median of 15.70. Over the past 10 years, this metric has ranged from a low of 11.95 to a high of 20.65. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.07. Intuitive Surgical's value of 19.27% is 373.5% above this industry median. Based on the distribution chart, Intuitive Surgical ranks #146 out of 759 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Intuitive Surgical has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intuitive Surgical's Return-on-Tangible-Equity compare to BDX and MDLN?
According to the Medical Devices & Instruments industry distribution chart, Intuitive Surgical ranks #146 out of 759 companies for Return-on-Tangible-Equity. This places Intuitive Surgical in the top 19% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.07. Intuitive Surgical's value of 19.27% is 373.5% above this benchmark. Historically, Intuitive Surgical's own Return-on-Tangible-Equity has ranged from 11.95 to 20.65 over the past decade. While the company's 10-year median is 15.70 vs. the industry median of 4.07, Intuitive Surgical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.07, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Intuitive Surgical's current Return-on-Tangible-Equity of 19.27% is 373.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Intuitive Surgical and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intuitive Surgical's current Return-on-Tangible-Equity is 19.27%, which is 23% above median its own 10-year median of 15.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intuitive Surgical stock overvalued right now?
Based on GuruFocus' analysis, Intuitive Surgical (MEX:ISRG) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN10,532.16, compared to a current price of MXN7,434.47 — trading 29.4% below its estimated fair value. The current Return-on-Tangible-Equity is 19.27%, which is 23% above median its 10-year median of 15.70 and 373.5% above the Medical Devices & Instruments industry median of 4.07. Intuitive Surgical's overall GF Score™ is 91/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Intuitive Surgical (MEX:ISRG), the current Return-on-Tangible-Equity is 19.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Intuitive Surgical (MEX:ISRG) Overvalued in 2026?
Based on GuruFocus' analysis, Intuitive Surgical stock appears to be undervalued.
The current stock price of MXN7,434.47 is trading 29.4% below its estimated GF Value™ of MXN10,532.16.
GuruFocus considers Intuitive Surgical to be Modestly Undervalued.
Key valuation signals for MEX:ISRG:
Return-on-Tangible-Equity: 19.27% (23% above median its 10-year median of 15.70)
GF Value™: MXN10,532.16 vs. price of MXN7,434.47 (29.4% below fair value)
Industry Position: 373.5% above the Medical Devices & Instruments median (#146 of 759)
No single metric tells the full story. See the MEX:ISRG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
91GF Score
Get the complete analysis for MEX:ISRG
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:ISRG has been successfully added to your 
